TCW Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

TCW Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-12,492	Closed	-$2.16M	–	758
2015 Q1	$2.16M	Sell	12,492 -101,700	-89%	-$14.9M	0.01%	611
2014 Q4	$13.1M	Buy	114,192 +49,089	+75%	+$5.95M	0.05%	225
2014 Q3	$10.2M	Buy	+65,103	New	+$9.44M	0.04%	323

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

TCW Group's SLXP Position: Q2 2015 in Review

TCW Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 12,492 shares — an estimated $2.16M sold.

TCW Group first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $13.1M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

TCW Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
TCW Group sold 12,492 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $2.16M.
TCW Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
TCW Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $13.1M in Q4 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on TCW Group's 13F filing for Q2 2015, filed 12 Aug 2015.